Thomas Bartlett
Founder Amgen
Seminars
Wednesday 22nd July 2026
Are We Measuring the Right Things? A Patient’s Perspective on Digital Endpoints, Clinical Reality & Trial Retention in Myasthenia Gravis
11:00 am
- Why current MG assessments often fail to reflect the day-to-day reality of fluctuating symptoms and functional impairment
- Using digital technologies and real-world data to move beyond subjective questionnaires and create more meaningful measures of treatment benefit
- Rethinking patient retention and engagement in clinical trials by addressing the factors that matter beyond the therapeutic itself
